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Apoptosis Is Inversely Related to Necrosis and
Determines Net Growth in Tumors Bearing
Constitutively Expressed myc, ras, and HPV
Oncogenes
Mark J. Arends, Angus H. McGregor, and
Andrew H. Wyllie
From the Cancer Research Campaign Laboratories,
Depattment of Pathology, University Medical School, Teviot
Place, Edinburgh, UJnited Kingdom
Immortalized rat fibroblasts were transfected
with expression plasmids containing a mutated
human Ha-ras (T24) oncogene, human c-myc,
HPV 16 or 18genomes, or combinations ofthese.
CeUproliferation rates in vitro ofthe resulting 13
transformed lines were closely similar but apop-
totic rates in vitro varied overa 60-fold range and
correlated inversely with rates ofpopulation ex-
pansion in culture. To determine whether such
differences in susceptibility to apoptosis affected
the pattern of tumor growth in vivo, the trans-
fected lines were injected subcutaneously into im-
munesuppressed mice producingfibrosarcomas
in whichprevalence ofapoptosis and mitosis, ex-
tent ofnecrosis, and net growth rate were meas-
ured Cell lines with high apoptotic rates in vitro
tended to generate slowly growing tumors with
high ratios of apoptosis to mitosis and little ne-
crosis. The three most extreme examples of this
phenotype aUl resultedfrom single transfections
with c-myc Lines with low apoptotic rates in vitro
generated rapidly expanding tumors with high
mitotic rates, extensive necrosis, and little apop-
tosis relative to mitosis, even in the compromised
zone at the edge of necrotic regions. The four
fastest-growing tumors all contained a T24-ras on-
cogene. The results suggest that oncogene expres-
sion determines intrinsic apoptotic rates and in
this way may significantly influence the net
growth rate and extent of necrosis in tu-
mors. (AmJ Pathol 1994, 144:1045-1057)
Many factors influence the rate of tumor growth. Tu-
mor cell proliferation has been extensively studied but
does not correlate well with overall growth rate.1 Part
of the reason for this is that tumor growth results from
the balance of cell gain with cell loss, and quantitative
data indicate that cell loss from growing tumors is
considerable. Overall cell loss can be measured as
the cell loss factor (CLF), which expresses the differ-
ence between the growth expected of a tumor on the
basis of its cell proliferation rate and the observed
growth rate.2 CLFs of 1 indicate that cell loss bal-
ances cell gain exactly and CLFs of 0 indicate that all
proliferating cells are retained alive. Recorded values
of CLFs in rodent sarcomas and carcinomas are in the
range of 0.65 to 0.78, whereas for human bronchial,
colorectal carcinomas, and malignant melanomas
they are higher still at 0.73 to 0.96.2-5
The two main mechanisms of cell loss from growing
tumors are apoptosis and necrosis.6'7 Apoptosis is
genetically programmed and usually affects single
cells surrounded by viable neighbors. In contrast, ne-
crosis results from severe nonphysiological perturba-
tion of the cellular environment and often occurs in
confluent zones within tumors. The topography of ne-
crosis in tumors is a complex function, a major de-
terminant of which is the rate of proliferation of tumor
cells relative to the process of angiogenesis, itself in-
duced by tumor-derived growth and angiogenic
factors.2-4 8 Blood flow within tumors is notably het-
erogeneous and is not always directly proportional to
the anatomic extent of their vasculature.9 Local re-
gions of rapid tumor expansion may produce zones
of hypoxia resulting in necrosis. This has been ob-
served at a strikingly constant distance from blood
vessels or oxygen supply as within experimental tu-
mor "spheroids" in vitro and "corded carcinomas" in
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vivo.3,4,8-13 However, despite the histologically con-
spicuous appearance of necrosis, it is by no means
established that it can account for the high tumor
CLFs observed. Apoptosis is less conspicuous his-
tologically because it is swiftly completed, leaves no
residua, and occurs in a scattered topographical dis-
tribution. It is readily calculated that a surprisingly
small proportion of apoptotic cells visualized in a tis-
sue section can represent very substantial cell
loss14 15 but there are few quantitative reports on ap-
optosis in tumors.7,16-21
The patterns of cell death within the microenviron-
ment of growing tumors are important, because they
express fundamental features of tumor biology and
therefore may relate to prognosis. Diagnostic his-
topathologists are familiar with the somewhat coun-
terintuitive notion that tumors with a large proportion
of necrosis have a bad prognosis.22 The tumor mi-
croenvironment may also influence the response to
therapy, because hypoxia diminishes the cytotoxicity
of ionizing radiation23'24 and alters the expression
and efficiency of drug metabolizing enzyme sys-
tems.3'25 Furthermore, local permeation of systemic
chemotherapeutic agents must be affected by the de-
tailed topographical relationships between tumor
cells and the microcirculation.26 Moreover, many re-
cent observations of cells in vitro show that suscep-
tibility to apoptosis is regulated by the expression of
oncogenes and oncosuppressor genes and that this
may have much to do with their sensitivity to cytotoxic
agents of various types.27-31
In this paper we explore the possibility that apop-
tosis may be important in determining net tumor
growth and patterns of tumor necrosis by comparing
parameters of growth in vivo with those in vitro. We
describe differences in the apoptotic rates of a family
of cell lines derived from a single parental rat fibro-
blast line by transfection with myc, ras and HPV
genes. We show that these differences in apoptosis
are responsible for the widely divergent overall
growth rates of the lines in vitro and are conserved in
vivo where they contribute to differences in tumor
growth rate. Differences in susceptibility to apoptosis
correlate inversely with the tendency to develop ne-
crosis. The data provide evidence that oncogenes
regulate apoptosis in tumors and by this means de-
termine important elements of the growth patterns of
these tumors in vivo.
Materials and Methods
Construction of the Cell Lines
The immortal but untransformed Fischer rat lung fi-
broblast line 208F32 was transfected with expression
vectors containing human c-myc, mutationally acti-
vated human c-Ha-rasl (T24-ras), and HPV 16 and 18
genomes as described elsewhere.33-3 In all, 14 cell
lines were investigated (Table 1): the control untrans-
fected parent (208F), 3 sublines transfected with
c-myc (Mi, M7, and M8), 3 transfected with T24-ras
(Ti, T2, and T3), 3 c-myc/T24-ras co-transfectants
(MT7, MT9, and MT10), and 4 HPV-containing trans-
fectants of which 1 received HPV 16 alone (H16), 1
HPV 18 alone (H18), and 2 were HPV/T24-ras co-
transfectants (H16R, H18R). The MT7 cell line was
derived from Ti cells by electroporation with the
c-myc expression plasmid pHRMCGM1.3 MT9 and
MT10 were co-transfectants both derived from 208F
by simultaneous electroporation with c-myc and T24-
ras expression plasmids (pHRHMCGMl and
pHRHO5Ti).35 H16 and H18 were derived by elec-
troporation of 208F with pJ4f1H6/pSV2Neo and
pJ4fQ18/pSV2Neo, respectively,34 whereas H 1 6R
and H 18R were derived by co-transfection with
pJ4fQ 6/pHO5Tl and pJ4fQ 8/pHO5Tl, respec-
tively.33'34 These mixed transfectants were selected
with either hygromycin B or G418 (geneticin) and
single colonies isolated as clones. The presence of
transfected DNA was confirmed by Southern hybrid-
ization analysis or polymerase chain reaction using
specific primers (data not shown).35-38 The c-myc
RNA expression was confirmed by reverse
transcription-polymerase chain reaction using exon
connection primers and also by RNA dot blot hybrid-
ization analysis (data not shown) and enhanced
p21ras expression was confirmed by immunocyto-
chemistry.35
Cell Growth In Vivo
Groups of 6 to 11 immunosuppressed CBA mice re-
ceived 10 million cells by subcutaneous injection39
for each cell line. After 12 days animals were killed
and autopsied. At this stage most animals appeared
healthy but those injected with Ti and MT7 cells bore
large tumors and pilot experiments showed that if left
undisturbed they died a few days later.39 In a sepa-
rate series of experiments mice injected with Mi cells
were kept for periods of up to 70 days to generate
tumors of comparable size to the fast-growing Ti tu-
mors at 12 days. At autopsy, three mutually perpen-
dicular tumor diameters were measured and multi-
plied together to express tumor size as a "box
volume" (cm3). Tumors were bisected and one-half
analyzed histologically after fixation in periodate-
lysine-paraformaldehyde-dichromate, preparation of
paraffin sections, and staining with hematoxylin and
eosin. The extent of tumor necrosis was assessed
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semiquantitatively on a scale of 0 to 4, where 4 rep-
resented >75% necrosis (by area), 3 represented 50
to 75% necrosis, 2 represented 25 to 50% necrosis,
1 represented small scattered islands of necrosis
<25% total area, and 0 stood for absence of necrosis.
Six tumors from each cell line were assessed for ex-
tent of necrosis and the mean necrosis score was
calculated and multiplied by 10. The number of mi-
totic and apoptotic figures were identified by stand-
ard criteria14'15,40 and counted in the same fields over
10 high power fields selected within viable portions of
each tumor. The raw data for apoptotic counts and
mitotic counts were combined to form ratios of
apoptosis/mitosis (A/M). This corrects for differences
in density of apoptosis and mitosis per field that de-
rive solely from factors such as cell size and the den-
sity of cell packing within the tumors. A/M ratios and
rates of apoptosis in culture were log transformed to
render the data near-Gaussian in distribution to allow
statistical comparison by the Student's t-test. In tu-
mors this was based on at least 60 data points (10
high power fields from each of at least 6 tumors from
each cell line).
Growth In Vitro
This was studied in cultures in 75-cm2 flasks seeded
with 8 x 105 cells. Apoptosis was measured by col-
lecting media at 48 hours. Cell bodies released from
the monolayer into the media (released cell bodies,
RCB) were resuspended in a known volume of
phosphate-buffered saline and the total numbers of
RCB were counted using an improved Neubauer he-
mocytometer. The 20 p1 of this sample was mixed with
an equal volume of 10 pg/ml acridine orange on a
glass slide and viewed under ultraviolet light. The 100
to 200 cellular bodies were counted and identified as
viable, apoptotic, or necrotic, differentiated by their
characteristic morphological appearances.14'15 This
was used to calculate the proportion of apoptotic
bodies (%A) and viable (%V) cells comprising the
RCB. The monolayer was carefully harvested by
trypsin-EDTA digestion35 and counted to give the to-
tal number of monolayer cells (MC), including any re-
sidual cells collected by a thorough phosphate-
buffered saline wash of the flask. The apoptotic index
(Al) was calculated as a measure of the production of
apoptotic bodies per 100 attached cells over 48 hours
using the following equation: Al = [%A x RCB x 100]/
[(%V x RCB) + MC] and a mean Al for each cell line
was derived from 5 to 10 replicate experiments.
Cell Cycle Analysis
This was performed on trypsinized, washed cell sus-
pensions using a standard protocol for flow cytomet-
ric measurement of the nuclear DNA content.4 Cells
were analyzed while growing in maximal growth
phase in culture. The computer software program,
SFITS (Coulter Electronics), was used to determine
the proportion of cells in each phase of the cell cycle.
The growth fraction was calculated as the proportion
of cells in S plus G2/M phases of the cell cycle (9 to
10 experiments per cell line). The ratio of the mean
monolayer cell numbers at 48 and 24 hours (termed
population expansion, PE) was used as a single
measure of the proportional increase in cell number
over 1 day. This allowed comparison of the increases
in net cell numbers between different cell lines while
in maximal growth phase (3 to 9 experiments per cell
line).
Results
Growth In Vitro
Morphological Phenotype
The parental 208F cell line demonstrated topoin-
hibition of growth in culture by forming a flat confluent
monolayer of nonrefractile, nontransformed polygo-
nal cells. Controls for subsequent experiments in-
cluded untransfected 208F cells, cells electroporated
with no DNA, or transfected with either the drug se-
lection vector only (pSV2Neo) or viral enhancer/
promotor sequences and drug selection vector only
(pHomer5), all of which showed no evidence of mor-
phological transformation. The three c-myc trans-
fected cell lines all demonstrated morphological fea-
tures of a mild degree of transformation. The flat,
spindle-shaped cells were more refractile than the pa-
rental line and there was tight side-to-side clustering
of cells producing a fascicular appearance with for-
mation of small foci (2 to 3 cells high). The c-myc
transcripts were previously estimated at approxi-
mately 0.5% of total cellular mRNA in Ml cells, ap-
proximately 18-fold higher than untransfected 208F
controls,39 and semiquantitative dot blot analysis of
myc RNA levels in M7 and M8 showed approximate
equivalence to those in Ml cells (unpublished data).
The T24-ras-containing lines Ti, T2, T3, MT7, H16R,
and H18R all showed a markedly transformed phe-
notype. Their cells were tubular or spindle shaped,
strongly refractile, and piled up to more than three
cells' depth in large foci (Figure 1). T24-rastranscripts
were previously estimated at around 0.8% of total cel-
lular mRNA in Ti cells, approximately 20-fold greater
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Figure 1. Phase contrast photomicrographs ofgrowth pattern in culture of the parenital cell litne 208F the three c-myc tran.sLctants MI, M7, anid
M8, anid the three T24-ras transf/ictants Ti, T2, and 73 ( x250).
than untransfected 208F cells39, and immunocyto-
chemical analysis of p21 ras protein expression
showed 1 0-fold higher levels for Ti, 4-fold higher for
T2 cells, and 2-fold higher for T3 cells compared with
208F controls.35 The myciras cotransfectants MT9
and MT10 and the HPVtransfectants H16 and H18 all
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showed intermediate degrees of transformation with
limited piling up of moderately refractile cells (data
not shown).
Growth Fractions and Population Expansion
All transfectants had closely similar growth frac-
tions in culture (Table 1). The only statistically signifi-
cant differences were between M7 and MT9 (P =
0.02) for the oncogene transfectants and between
H 18 and H 16R (P < 0.05) for the HPV-containing cell
lines. However, PE values differed greatly between
the 14 lines and showed a strong inverse correlation
(r = -0.65) with the log Al in culture (regression equa-
tion log Al = 1.27 -0.349 PE; P = 0.012) (Figure 2).
Apoptosis
Transfected fibroblasts die in culture by apoptosis,
as previously characterized ultrastructurally and by
chromatin cleavage.14'35 Al in culture varied over 60-
fold between lowest and highest mean values. The
three pure c-myc transfectants (Mi, M7, and M8)
showed significantly higher levels than the control
208F (P < 0.05 in all cases) (Table 1). The T24-ras-
containing transfectant Ti and its derivative MT7
showed significantly reduced apoptosis compared
with the control 208F (P< 0.015). Ti, T2, and MT7 all
had significantly less apoptosis than the three pure
c-myc transfectants (P < 0.025). Of the lines derived
from simultaneous co-transfection with myc and ras,
MT10 had a similar log Al and MT9 a significantly
higher log Al than 208F (P < 0.01), but both had sig-
nificantly lower log Als than the two pure myc trans-
fectants M7 and M8 (P < 0.05). Among the HPV-
containing lines, the only significant difference was
between H18R and H18 (P = 0.028) due to reduced
apoptosis associated with ras in combination with
HPV 18 compared with HPV 18 alone.
Growth In Vivo
Malignant Phenotype
Earlier experiments39 (unpublished observations)
had established that the parental 208F line produces
small indolent nodules, nonprogressive over periods
of a month or more, whereas the oncogene transfec-
tants usually generate tumors that grow at different
rates but are eventually lethal. In the 12-day study
period of the present experiments the T24-ras, c-myc,
and HPV transfectants each formed invasive tumors
in all of the six to seven injected mice. As expected
the parent cells (208F) formed small nodules with no
histological evidence of invasion of skin or muscle in
10 of 11 mice and no residual lesion in the 11th.
AIM Ratio
When apoptosis was studied relative to mitosis
(A/M ratio) in the cell lines growing as tumors in vivo
a pattern emerged similar to the observations of ap-
optosis in vitro (Table 1). The three pure c-myc trans-
fectants (Mi, M7, and M8) and 208F each had A/M
tios that were significantly higher than those of the
T24-ras-containing transfectants Ti, T2, and MT7
(P < 0.01 for all comparisons). The simultaneous co-
transfectants MT9 and MT10 had intermediate A/M
ratios that were also significantly lower than 208F, Mi,
M7, and M8 (P < 0.01). Tumors formed by H16 had
Table 1. Growth Parameters In Vitro and In Vivo
Transfected Growth Population Apoptosis Tumor
Cell Enhancer/ Fraction Expansion Index (log) Tumor Tumor Tumor A/M Tumor
Line Oncogene In Vitro In Vitro In Vitro Size Mitosis Apoptosis Ratio (log) Necrosis
208F Parent 35.6 1.53 2.62 (0.42) 0.29 1.03 2.8 3.36 (0.53) 0
Ml Mo/myc 40.4 2.89 4.57 (0.66) 0.37 3.4 7.3 2.92 (0.47) 1.7
M7 Mo/myc 29.8 1.54 41.52 (1.62) 0.51 9.6 22.6 3.18 (0.50) 13.3
M8 Mo/myc 39.9 1.20 15.44 (1.19) 0.13 1.95 12.9 7.47 (0.87) 5.0
Ti SVIras 40.1 3.56 0.77 (-0.11) 2.20 18.2 3.9 0.22 (-0.66) 31.7
T2 SVIras 38.9 3.67 1.83 (0.26) 2.25 18.2 11.6 0.64 (-0.20) 21.7
T3 SV/ras 36.6 1.77 8.44 (0.93) 2.20 6.35 11.1 1.89 (0.28) 14.2
MT7 SV/ras and Mo/myc 33.1 4.06 0.62 (-0.21) 2.42 26.1 4.1 0.17 (-0.77) 40.0
MT9 Molmyc and SV/ras 43.7 1.67 5.95 (0.78) 1.02 12.2 3.6 0.30 (-0.52) 12.5
MT10 Molmyc and SV/ras 40.8 2.30 2.30 (0.36) 1.42 16.1 10.9 0.69 (-0.16) 16.7
H16 Mo/HPV16 34.7 2.19 1.28 (0.11) 0.41 12.8 20.3 1.77 (0.25) 26.7
H16R Mo/HPV16 and SVIras 31.9 1.52 1.22 (0.09) 0.99 14.9 6.2 0.48 (-0.32) 28.3
H18 Mo/HPV18 42.9 1.71 1.56 (0.19) 1.05 16.7 11.5 0.69 (-0.16) 17.5
H18R Mo/HPV18 and SVIras 34.7 3.71 0.74 (-0.13) 0.92 17.0 3.1 0.19 (-0.73) 21.7
Transfected enhancer/oncogene sequences: Mo, Moloney virus long terminal repeat enhancer; SV, SV40 enhancer; myc, c-myc proto-on-
cogene; ras, mutated c-Ha-ras; oncogene; growth fraction, S+G2/M phases (ave. 9 to 10 expts.); population expansion (ave. 3 to 9 expts.);
apoptotic index (ave. 5 to 10 expts.); tumor size (ave. 6 to 10 expts.); tumor mitotic counts (ave. 60 high power fields); tumor apoptotic
counts (ave. 60 high power fields); A/M ratio was calculated by dividing counts/10 high power fields for each of 10 high power fields in 6
tumors (ave. 60); tumor necrosis extent assessed semiquantitatively using an arbitrary scale (ave. 6 tumors).
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significantly higher A/M ratios than those generated
by H18 (P < 0.005). A/M ratios in H18R tumors were
as small as those of Ti and MT7 and were significantly
lower than those in H16 tumors (P < 0.002) and H18
tumors (P< 0.004). Unlike the results in vitro, however,
the different transfectants showed divergent absolute
mitotic counts. All exceeded that of the parental line
and the highest three were all T24-ras-containing
transfectants (Ti, T2, and MT7), whereas the pure
c-myc transfectants showed generally low values.
Apoptosis in culture, as measured by the log ap-
optotic index, correlated well (r = 0.73) with apoptosis
relative to mitosis (log A/M) in tumors in vivo (regres-
sion equation log Al = 0.473 + 0.738 log A/M; P =
0.003). The three c-myc transfectants Mi, M7, and
M8 had high levels of apoptosis both in vitro and in
vivo, whereas the T24-ras-containing lines Ti, T2, and
MT7 showed low values for both, and combinations of
HPVlraslmyc were intermediate (Figure 3, A).
Tumor Size
All transfectants formed tumors that were larger in
size than the indolent nodules formed by the parent
cell line 208F. The sizes of the primary tumors formed
by the T24-ras transfectants Ti, T2, T3, and MT7 were
significantly greater than those of the pure c-myc lines
Mi, M7, and M8 (P < 0.01), as were those of the two
co-transfectants MT9 and MT10 (P< 0.015) (Table 1).
Tumor sizes for the 14 lines showed an inverse cor-
relation (r = -0.64) with log A/M ratios (regression
equation tumor size = 1.11 - 0.973 log A/M; P =
0.015) (Figure 3B) and a positive correlation with ab-
solute mitotic counts (r = 0.68; regression equation
tumor size = 0.208 + 0.076 tumor mitosis; P = 0.008).
Absolute mitotic count data should be interpreted
with caution because potentially confounding topo-
graphical features (such as cell size and density) are
not taken into account. Furthermore, population ex-
pansion in culture correlated positively (r = 0.61) with
tumor size (regression equation PE = 1.52 + 0.741
tumor size; P = 0.022). Hence, the ras-containing
transfectants Ti, T2, and MT7 showed high levels of
net growth both in vitro and in vivo, whereas the pure
myc transfectants Mi, M7, and M8 had low values of
both, and the HPV/ras/myc combinations were mostly
intermediate.
Tumor Necrosis
For all 14 cell lines, tumor necrosis score demon-
strated a good correlation with absolute mitotic
counts (r = 0.90; regression equation necrosis =
0.18 + 1.42 tumor mitosis; P < 0.0001) (Figure 4A)
and with tumor size (r = 0.65; regression equation
tumor size = 0.333 + 0.0459 necrosis; P = 0.012) but
a strong inverse correlation with tumor apoptosis rela-
tive to mitosis (r = -0.75; regression equation necro-
sis = 17.2 - 16.3 log A/M; P = 0.002) (Figure 4B).
Furthermore, tumor necrosis score correlated in-
versely with measures of apoptosis in culture (r =
J
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Figure 3. Scatterplots of apoptosis relative to mitosis (log A/M ratio) in tumors versus (A) apoptosis in culture expressed as log AI (correlation r
0. 73) and (B) tumor size (correlation r = -0.64).
-0.66; regression equation necrosis = 24.2 - 14.2 log
Al; P = 0.01) (Figure 4C). Thus, the extent of necrosis
appears to reflect both tumor size and proliferation
rate in vivo but nevertheless is strongly inversely re-
lated to apoptosis.
Relationship Between Apoptosis and
Necrosis in the Tumor Microenvironment
The data presented above demonstrate the negative
correlation between extent of necrosis and preva-
lence of apoptosis in the tumors formed by the dif-
ferent cell lines. In these evaluations care was taken
to measure apoptosis only in viable parts of the tu-
mors (Figure 5, A and B) distant from necrotic regions.
In the course of this assessment, however, we noticed
that the zones of confluent necrosis observed in the
tumors were often surrounded by a rim of viable tumor
cells densely admixed with apoptotic cells. The size
of the necrotic zone and the thickness of the apoptotic
rim tended to vary depending on the transfected
gene. The group of T24-ras lines Ti, T2, T3, and MT7
formed large tumors containing extensive areas of
confluent necrosis with only a thin rim of apoptosis at
the interface between viable and necrotic tissue.
Overall, their necrosis scores were moderate or high
(Table 1). In contrast, in the 12-day time interval stud-
ied, the three pure c-myc transfectants Ml, M7, and
M8 generated small tumors that showed only occa-
sional small zones of necrosis and these were sur-
rounded by thick rims of apoptosis at the viable ne-
crotic boundaries. The HPVlraslmyc combinations
were mostly intermediate in tumor size and propensity
for necrosis with apoptotic rims of variable thickness.
To study this further, Ml and Ti tumors were com-
pared in animals that had been left undisturbed until
comparable tumor sizes were achieved. Ti tumors
were harvested between 8 and 12 days after inocu-
lation, whereas Mi tumors of comparable size were
only achieved after various periods up to 70 days. In
this experiment, 21 mice were injected with Mi cells
and left for 12 to 70 days. Of these, 13 mice devel-
oped tumor nodules of which 6 were small (less than
1 cm in maximum dimension) and showed no signifi-
cant necrosis but 7 were of large size, similar to Ti 8-
to 12-day tumors. Five of the seven large Mi tumors
did contain zones of necrosis and in every case the
edge of the necrotic zone showed large numbers of
apoptotic cells (Figure 5C). The five large Ml tumors
containing necrotic zones were analyzed for tumor
apoptosis and mitosis in their viable zones; apoptotic
counts increased to higher levels than those of the
standard 12-day Ml tumors (mean tumor apoptosis
20.0) as did tumor mitosis (mean 13.0) but the A/M
ratio decreased slightly to 1.66. In contrast, apoptotic
cells were rare in Ti tumors even at the interface be-
tween viable and necrotic regions (Figure 5D). Thus,
the extent of apoptosis at the viable necrotic bound-
aries appeared to reflect the susceptibility to apop-
tosis in the viable regions elsewhere in the tumor.
Discussion
Apoptosis Has a Major Influence on Net
Tumor Growth Rate
The data confirm the importance of apoptosis in de-
termining the growth of tumor cell populations. Analy-
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sis of growth parameters of the 14 cell lines in culture
revealed similar growth fractions in the different trans-
fectants but widely divergent rates of cell population
expansion and apoptosis. Population expansion and
apoptosis showed a statistically significant inverse re-
lationship. Thus, the rate of apoptosis appeared to be
the major variable determining differences in the rate
of population expansion in vitro. The sizes of tumors
formed in vivo by these transfectants also correlated
with their population expansion in vitro and showed
an inverse correlation with A/M ratios in vivo. Histo-
logically, all were moderate or poorly differentiated
fibroblastic tumors, thus differentiation, as a means of
exit from the proliferating pool, was most unlikely to be
significant. The ratio of apoptosis to mitosis reflects
changes in both numerator and denominator and
should be interpreted with caution but it has been
used successfully by others to study frequency of ap-
optosis in histological sections.42 The fact that the
rates of apoptosis in vitro correlated closely with the
Figure 4. Scatter plots of tumor necrosis scores versus (A) abso-
luite mitotic counts fromn tumors (correlation r = 0.90), (B) log
A/M ratios of transfe-ctants growing as tumors (correlation r =
-0. 75), anid (C) log apoptotic index in culture (correlation r =
-0.66).
A/M ratio in tumors in vivo suggested to us that the
rate of cell turnover within these tumors was deter-
mined by intrinsic susceptibility to apoptosis rather
than by environmental factors alone.
Susceptibility to Apoptosis may
Determine the Probability of Tumor
Necrosis
The extent of necrosis in tumors is difficult to measure
accurately and objectively and was assessed only
semiquantitatively in this study. Necrosis showed a
positive correlation with tumor size and prevalence of
mitosis in tumors but an inverse correlation with the
ratio of apoptosis to mitosis in vivo and with its in vitro
homologue, Al. There appeared to be a spectrum of
the pattern of cell death within this family of tumors.
In some tumor types death occurred mostly by ap-
optosis with little necrosis. This was seen in slowly
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Figure 5. Photomicrographs of the patterns of tumor death from (A) a c-myc transfectant (M7) viable tumor region displaying frequent apoptosis
(arrow heads) relative to mitosis, (B) a T24-ras transfectant ( T1) viable tumor region showving plentiful mitotic (arrows) butfeuw apoptotic figures,
(C) a c-myc tranKsfectant (MI) large tutmor shooing a small area of necrosis (N) with considerable apoptosis (zone between bars) at the boundary
region; and (D) a T24-ras tran,ssfectant (Ti) displayving a large zonie of con?fluent necrosis (N) uwith onlv a thin rm of apoptosis (zone between
bars) at the necrotic viable inteifjice (hematoxylin anid eosin, X 250).
growing tumors, as exemplified by those formed by
myc transfectants. At the other end of the spectrum,
tumor cells died largely by necrosis with little apop-
tosis, a pattern observed in rapidly growing tumors
such as those formed by ras transfectants. HPV/ras/
myc combinations displayed intermediate proper-
ties.
A simple explanation for this inverse relationship
between apoptosis and necrosis in tumors is that the
intrinsic cellular susceptibility to apoptosis deter-
mines the probability of necrosis. Cellular sensitivity
or resistance to apoptosis in response to one type of
injury stimulus is often associated with similar sensi-
tivity or resistance to a variety of other agents.2R43
We have argued elsewhere that this is because some
cell types are "primed" for apoptosis.14 Indeed, we
have already shown in some of the cell lines studied
here that those most and least susceptible to apop-
tosis differ in their content of a nuclear endonuclease
activity that may be one of the effector proteins of
apoptosis.35
We therefore propose that during growth in vivo
tumor cells that are primed for apoptosis are liable to
die by apoptosis in adverse conditions such as mild
ischaemia, reduction in availability of essential sub-
strates and growth factors, or falling pH. In contrast,
cells that are intrinsically less susceptible to apopto-
sis might be more resistant to these conditions and
therefore survive, at least initially, within deviant tumor
microenvironments. Low susceptibility to apoptosis is
thus likely to associate with both rapid expansion of
the tumor cell population and the development within
the tumor of zones of hypoxic but viable tumor cells.
Eventually, necrosis is the obligate mode of death of
these cells, whether provoked by the progressive im-
balance between growth of the tumor and that of its
supporting blood supply, or by more acute vascular
events (compression, thrombosis, or spasm). We
made no attempt to measure angiogenesis or blood
flow directly but this proposition is supported by the
exceptionally high incidence of apoptosis at the
viable/necrotic boundary in those c-myc-transfected
tumors in which necrosis did occur, in contrast to its
low incidence at similar locations in ras-expressing
tumors of similar size.
One alternative explanation for the inverse relation-
ship between apoptosis and necrosis might be that
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necrosis in these subcutaneous rodent fibroblast tu-
mors is simply determined by tumor size. Two inde-
pendent observations argue against this. First, the ex-
tent of necrosis does not automatically reflect tumor
size. Tumors of very similar sizes such as MT7, Ti, T2,
and T3 had mean necrosis scores varying from 14.2
to 40. Second, the c-myc tumors in the series that
were allowed to grow to large size still showed less
necrosis than ras tumors of comparable size. Thus,
although the ratio of tumor volume to functional vas-
cular supply is undoubtedly important in determining
which tumor zones become hypoxic, the hypothesis
advanced here does not rest exclusively on the time-
honored notion that proliferating tumor cells outgrow
their blood supply. Rather, it indicates that cellular
susceptibility to apoptosis may prevent development
of a severely deviant microenvironment and therefore
limit the extent of necrosis.
Oncogenes Determine Patterns of Tumor
Death
The preceding paragraphs have emphasized the in-
trinsic differences in apoptotic rates in the various
transfected derivatives of 208F and the significance
of this in determining the overall tumor growth rate
and, perhaps, the conditions of the tumor microen-
vironment that favor or discourage necrosis. The
question arises whether these differences in apop-
tosis are themselves determined by the expression of
the transfected oncogenes. Although the presence of
the transfected genes was confirmed in all these cell
lines (and their expression in many), in experiments
of this design it is seldom possible to completely ex-
clude the possibility that critical but unidentified cel-
lular changes have been co-selected with expression
of the transfected gene during clonal expansion of the
cell line in vitro and in vivo. However, striking simi-
larities emerged between independent transfectants
expressing the same oncogene. In particular, pure
c-myctransfectants tended to be of the slow-growing,
high A/M ratio, low necrosis type, whereas the pure
ras transfectants showed the faster-growing, low A/M
ratio, extensive necrosis phenotype.
The intermediate position of most of the raslmycl
HPV co-transfectants may suggest gene dose-
dependent interactions. Recent data indicate that
constitutive c-myc expression in fibroblasts initiates
apoptosis under conditions of suboptimal growth
support, such as reduced serum growth factor ex-
posure in vitro.35'39'51 5 Under these circumstances,
expression of genes such as bcl-2, abl, and certain
viral oncogenes can rescue the myc-expressing cells
at the same time rendering them resistant to a variety
of pharmacologically unrelated lethal stimuli in
vitro.46,48-50,54-57 The data presented here strongly
suggest that constitutive c-myc expression has en-
tirely analogous effects in fibroblastic tumors growing
in vivo, and that expression of mutated Ha-ras, es-
pecially at the high levels that are found in the Ti
subline,33'35'39 has a survival effect similar to that of
bcl-2.
The two high risk HPV types were associated with
moderate to high levels of tumor cell apoptosis com-
pared with HPV/ras co-transfectant tumors, and it is
interesting that expression of the HPV-transforming
genes may stimulate myctranscription. Binding of the
retinoblastoma protein p105Rb (Rb) by HPV 16/18
E75860 has been reported to release Rb-mediated
repression of c-myc.6163 Rb itself can inhibit apop-
tosis in certain circumstances.64'65 However, binding
of HPV 16/18 E6 to p53, directing its rapid degrada-
tion,66 may block stimulation of apoptosis by wild-
type p53.30'67 Thus, HPV 16 and 18 genomes, which
are strongly implicated in the development of cervical
cancer37'38'68 may set in train many pathways, in-
cluding myc activation and p53 degradation, that
might have opposing effects on apoptosis.
It is clear that not all the phenotypic effects of on-
cogene transfection are explicable in terms of
changes in apoptosis alone. In ras transfectants, for
example, there is a consistent increase in the fre-
quency of mitotic events in vivo that is not evident in
vitro. Presumably, growth in vitro is rendered inde-
pendent of some of the cell proliferative effects of the
transfected ras gene through exogenous supply of
growth factors in the medium. Nonetheless, the data
presented here support the view that oncogene ex-
pression materially influences both the intrinsic sus-
ceptibility to apoptosis of tumor cells and its relation-
ship to cell proliferation and hence affects
fundamental features of the mode and rate of growth
in vivo and the character of the tumor microenviron-
ment.
The inverse relationship between apoptosis and
necrosis, in particular the association of low suscep-
tibility to apoptosis with fast net growth and extensive
necrosis, affords a rational basis for empirically de-
rived tumor grading systems that place emphasis on
the extent of necrosis as an indicator of poor prog-
nosis in many human tumors including soft tissue sar-
comas.3'4'22 Inclusion in such grading systems of an
indicator of tumor cell susceptibility to apoptosis,
such as absolute apoptotic levels, or A/M ratios, or
detection of preformed effector molecules of apop-
tosis such as endonuclease activity,69'70 or in situ end
labeling of fragmented DNA,15 may hold promise.
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Furthermore, because susceptibility or resistance of
tumor cells to induction of apoptosis by chemothera-
peutic drugs or irradiation appears also to be geneti-
cally determined, 27,29,30,31,46,71 such a modified
grading system that gives an indication of suscepti-
bility to apoptosis may also be useful in predicting
response to therapy.
Acknowledgments
We thank the Cancer Research Campaign, Scottish
Home and Health Department, Medical Research
Council, and Sir Stanley and Lady Davidson Lecture-
ship and Research Fund for financial support. We
also thank Elizabeth Foster for expert preparation of
the immunosuppressed mice.
References
1. Quinn CM, Wright NA: The clinical assessment of pro-
liferation and growth in human tumors: evaluation of
methods and applications as prognostic variables. J
Pathol 1990, 160:93-102
2. Steel GG: Growth Kinetics of Tumors, ed 1, Clarendon
Press, 1977
3. Moore JV: Cytotoxic injury to cell populations of solid
tumors. In Cytotoxic insult to tissue. Edited by Potten
CS, Hendry JH. Edinburgh, UK, Churchill Livingstone,
1983, pp 368-404
4. Moore JV: Death of cells and necrosis of tumors. In
Perspectives in Mammalian Cell Death. Edited by Pot-
ten CS. Oxford, UK, Oxford University Press, 1987, pp
295-325
5. Kerr KM, Lamb D: Actual growth rate and tumor cell
proliferation in human pulmonary neoplasms. Br J
Cancer 1984, 50:343-349
6. Wyllie AH: Cell death: a new classification separating
apoptosis from necrosis. In Cell Death in Biology and
Pathology. Edited by Bowen ID, Lockshin RA. London,
Chapman and Hall Press, 1981, pp 9-34
7. Wyllie AH: The biology of cell death in tumors. Anti-
cancer Res 1985, 5:131-136
8. Thomlinson RH, Gray LH: The histological structure of
some human lung cancers and the possible implica-
tions for radiotherapy. Br J Cancer 1955, 9:539-549
9. Tozer GM, Lewis S, Michalowsky A, Aber V: The rela-
tionship between regional variations in blood flow and
histology in a transplanted rat fibrosarcoma. Br J Can-
cer 1990, 61:250-257
10. Tannock IF: The relationship between cell proliferation
and the vascular system in a transplanted mouse
mammary tumor. Br J Cancer 1968, 22:258-273
11. Franko AJ, Sutherland RM: Oxygen diffusion distance
and development of necrosis in multicell spheroids.
Radiat Res 1979, 79:439-453
12. Jones B, Camplejohn RS: Stathmokinetic measure-
ment of tumor cell proliferation in relation to vascular
proximity. Cell Tissue Kinet 1983, 16:351-355
13. Rotin D, Robinson B, Tannock IF: Influence of hypoxia
and an acid environment on the metabolism and vi-
ability of cultured cells: potential implications for cell
death in tumors. Cancer Res 1986, 46:2821-2826
14. Arends MJ, Wyllie AH: Apoptosis: mechanisms and
roles in pathology. Int Rev Exp Pathol 1991, 32:223-
254
15. Arends MJ, Harrison DJ: Apoptosis: molecular as-
pects and pathological perspective. In Molecular As-
pects of Histopathology. Edited by J Crocker. Wiley &
Sons Ltd, Chichester, UK, 1994
16. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic
biological phenomenon with wide-ranging implications
in tissue kinetics. Br J Cancer 1972, 26:239-257
17. Kerr JFR, Searle J: A suggested explanation for the
paradoxically slow growth rate of basal cell carcino-
mas contain numerous mitotic figures. J Pathol 1972,
107:41-44
18. Wyllie AH, Kerr JFR, Currie AR: Cell death: the signifi-
cance of apoptosis. Int Rev Cytol 1980, 68:251-306
19. Sarraf CE, Bowen ID: Kinetic studies on a murine sar-
coma and an analysis of apoptosis. Br J Cancer 1986,
54:989-998
20. Sarraf CE, Bowen ID: Proportions of mitotic and apop-
totic cells in a range of untreated experimental tumors.
Cell Tissue Kinet 1988, 21:45-49
21. Bowen ID, Bowen SM: Programmed Cell Death in Tu-
mors and Tissues. London, Chapman and Hall, 1990
22. Enzinger FM, Weiss SW: General considerations. In
Soft Tissue Tumors, ed 2. Edited by Enzinger FM,
Weiss SW. St Louis, The CV Mosby Co., 1988, pp
1-18
23. Tannock IF: Oxygen diffusion and the distribution of
cellular radiosensitivity in tumors. Br J Radiol 1972,
45:515-524
24. Franko AJ, Sutherland RM: Radiation survival of cells
from spheroids grown in different oxygen concentra-
tions. Radiat Res 1979, 79:454-467
25. Shan X, Aw TY, Smith ER, lngelman-Sundberg M,
Mannervik B, lyanagi T, Jones DP: Effect of chronic
hypoxia on detoxication enzymes in rat liver. Biochem
Pharmacol 1992, 43:2421-2426
26. Hirst DG, Joiner B, Hirst VK: Blood flow modification
by nicotinamide and metoclopramide in mouse tumors
growing in different sites. Br J Cancer 1993, 67:1-6
27. Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier
Y: Differential induction of secondary DNA fragmenta-
tion by topoisomerase 11 inhibitors in human tumor cell
lines with amplified c-myc expression. Cancer Res
1991, 51:6280-6285
28. Gregory CD, Dive C, Henderson S, Smith CA, Williams
GT, Gordon J, Rickinson AB: Activation of Epstein-Barr
virus latent genes protects human B cells from death
by apoptosis. Nature 1991, 349:612-614
1056 Arends et al
AJP May 1994, Vol. 144, No. 5
29. Hickman JA: Apoptosis induced by anticancer drugs.
Cancer Metastasis Rev 1992, 11:121-140
30. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird
CC, Hooper MI, Wyllie AH: Thymocyte apoptosis in-
duced by p53-dependent and independent pathways.
Nature 1993, 362:849-852
31. Dive C, Wyllie AH: Apoptosis and cancer chemo-
therapy. In Frontiers in Pharmacology: Cancer Chemo-
therapy. Edited by Hickman JA, Tritton TT. Oxford, UK,
Blackwell Scientific, 1993, pp 21-56
32. Quade K: Transformation of mammalian cells by avian
myelocytomatosis virus and avian erythroblastosis vi-
rus. Virology 1979, 98:461-465
33. Spandidos DA, Wilkie NM: Malignant transformation of
early passage rodent cells by a single mutated human
oncogene. Nature 1984, 310:469-475
34. Storey A, Pim D, Murray A, Osborn K, Banks L, Craw-
ford L: Comparison of the in vitro transforming activi-
ties of human papillomavirus types. EMBO J 1988,
7:1815-1820
35. Arends MJ, McGregor AH, Toft NJ, Brown EJ, Wyllie
AH: Susceptibility to apoptosis is differentially regu-
lated by c-myc and mutated Ha-ras oncogenes and is
associated with endonuclease availability. Br J Cancer
1993, 68:1127-1133
36. Bos JL, Fearon ER, Hamilton SR, Verlaand de Vries M,
Van Boom JH, Van Der Eb AJ, Vogelstein B: Preva-
lence of ras gene mutations in human colorectal can-
cers. Nature 1987, 327:293-297
37. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird
CC: HPV in full thickness cervical biopsies: high
prevalence in CIN 2 and CIN 3 detected by a sensi-
tive PCR method. J Pathol 1991, 165:301-309
38. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird
CC: HPV 18 associates with more advanced cervical
neoplasia than HPV 16. Hum Pathol 1993, 24:432-437
39. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E,
Spandidos DA: Rodent fibroblast tumors expressing
human myc and ras genes: growth, metastasis and
endogenous oncogene expression. Br J Cancer 1987,
56:251-259
40. Baak JPA: Mitosis counting in tumors. Hum Pathol
1990, 21:683-685
41. Vindelov LL, Christensen IJ, Nissen N: Standardization
of high-resolution flow cytometric DNA analysis by the
simultaneous use of chicken and trout red blood cells
as internal reference standards. Cytometry 1983,
3:328-331
42. Allan DJ, Howell A, Roberts SA, Williams GT, Watson
RJ, Coyne JD, Clarke RB, Laidlaw IJ, Potten CS: Re-
duction in apoptosis relative to mitosis in histologically
normal epithelium accompanies fibrocystic change
and carcinoma of the premenopausal human breast. J
Pathol 1992, 167:25-32
43. Ucker DS: Cytotoxic T lymphocytes and glucocorti-
coids activate an endogenous suicide process in tar-
get cells. Nature 1987, 327:62-64
44. Wyllie AH: Apoptosis: cell death under homeostatic
control. Arch Toxicol 1987, 11 (Suppl):3-10
45. Henderson S, Rowe M, Gregory CD, Croom-Carter D,
Wang F, Longnecker R, Kieff F, Rickinson AB: Induc-
tion of bcl-2 expression by Epstein Barr Virus latent
membrane protein protects infected cells from pro-
grammed cell death. Cell 1991, 65:1107-1115
46. Fanidi A, Harrington EA, Evan GI: Interaction between
c- myc and bcl-2 protooncogenes: a novel paradigm
for oncogene cooperation. Nature 1992, 359:554-556
47. Sentman CL, Shutter JR, Hockenbery D, Kanagawa D,
Korsmeyer SJ: bcl-2 inhibits multiple forms of apopto-
sis but not negative selection in thymocytes. Cell
1991, 67:879-888
48. Strasser A, Harris AW, Bath ML, Cory I: Novel primitive
lymphoid tumors induced in transgenic mice by coop-
eration between myc and bcl-2. Nature 1990, 348:
331-333
49. Strasser A, Harris AW, Cory S: bcl-2 transgene inhibits
T cell death and perturbs thymic self-censorship. Cell
1991, 67:889-899
50. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams
JM, Cory S, Harris AW: Enforced bcl-2 expression in
B-lymphoid cells prolongs antibody responses and
elicits autoimmune disease. Proc Natl Acad Sci USA
1991, 88:8661-9665
51. Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G:
The apoptosis endonuclease and its regulation. Semin
Immunol 1992, 4:389-397
52. Askew D, Ashmun R, Simmons B, Cleveland J: Consti-
tutive c-myc expression in IL-3 dependent myeloid
cell line suppresses cycle arrest and accelerates ap-
optosis. Oncogene 1991, 6:1915-1922
53. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land
H, Brooks M, Waters CM, Penn LZ, Hancock DC: In-
duction of apoptosis in fibroblasts by c-myc protein.
Cell 1992, 69:119-128
54. Hockenbery D, Nunez G, Milliman C, Schreiber RD,
Korsmeyer SJ: BcI-2 is an inner mitochondrial mem-
brane protein that blocks programmed cell death. Na-
ture 1990, 348:334-336
55. Bissonnette RP, Echeverri F, Mahboubi A, Green DR:
Apoptotic cell death induced by c-myc is inhibited by
bcl-2. Nature 1992, 359:552-554
56. Evans CA, Owen PJ, Whetton AD, Dive C: Activation
of the Abelson tyrosine kinase activity is associated
with the suppression of apoptosis in haemopoietic
cells. Cancer Res 1993, 53:1735-1738
57. Sachs 1, Lotem J: Control of programmed cell death in
normal and leukemic cells: new implications for
therapy. Blood 1993, 82:15-21
58. Phelps WC, Yee CL, Munger K, Howley PM: The hu-
man papillomavirus type 16 E7 gene encodes trans-
activation and transformation functions similar to those
of adenovirus ElA. Cell 1988, 53:539-547
59. Munger K, Werness BA, Dyson N, Phelps WC, Harlow
E, Howley PM: Complex formation of human papillo-
Apoptosis, Necrosis, and Tumor Growth 1057
AJP May 1994, Vol. 144, No. 5
mavirus E7 proteins with the retinoblastoma tumor
suppressor gene product. EMBO J 1989, 8:4099-
4105
60. Munger K, Yee CL, Phelps WC, Pietenpol JA, Moses
HL, Howley PM: Biochemical and biological differ-
ences between E7 oncoproteins of the high and low
risk human papillomavirus types are determined by
amino terminal sequences. J Virol 1991, 65:3943-
3948
61. Moses HL, Yuang EY, Pietenpol JA: TGFf3 stimulation
and inhibition of cell proliferation: new mechanistic in-
sights. Cell 1990, 63:245-247
62. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R,
Lyons RM, Pittelkow MR, Munger K, Howley PM,
Moses HL: TGF-,B1 inhibition of c-myc transcription
and growth in keratinocytes is abrogated by viral
transforming proteins with pRB binding domains. Cell
1990, 61:777-785
63. Chittenden T, Livingston DM, Kaelin WG: The T/E1A-
binding domain of the retinoblastoma product can in-
teract selectively with a sequence-specific DNA-
binding protein. Cell 1991, 65:1073-1082
64. Clarke AR, Maandag ER, van Roon M, van der Lugt
NM, van der Valk M, Hooper ML, Berns A, te Riele H:
Requirement for a functional Rb-1 gene in murine de-
velopment. Nature 1992, 359:328-330
65. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell
MA, Weinberg RA: Effects of an Rb mutation in the
mouse. Nature 1992, 359:295-300
66. Scheffner M, Werness BA, Huibregste JM, Levine AJ,
Howley PM: The E6 oncoprotein encoded by human
papillomavirus types 16 and 18 promotes the degra-
dation of p53. Cell 1990, 63:1129-1136
67. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kim-
chi A, Oren M: Wild type p53 induces apoptosis of
myeloid leukaemic cells that is inhibited by interleu-
kin-6. Nature 1991, 353:345-347
68. Arends MJ, Wyllie AH, Bird CC: Papillomaviruses and
human cancer. Hum Pathol 1990, 21:686-698
69. Arends MJ, Morris RG, Wyllie AH: Apoptosis: the role
of the endonuclease. Am J Pathol 1990, 136:593-608
70. Wyllie AH: Glucocorticoid induced thymocyte apopto-
sis is associated with endogenous endonuclease acti-
vation. Nature 1980, 284:555-556
71. Evans DL, Dive C: Effects of cisplatin on the induction
of apoptosis in proliferating hepatoma cells and non-
proliferating immature thymocytes. Cancer Res 1993,
53:2133-2139
